Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Finasteride helps improve treatment for benign prostatic hyperplasia.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

The authors confirmed that β-estradiol inhibits hair growth in mice when used at the correct concentration.

Flutamide effectively treated hair growth and related symptoms in women, with common side effects like dry skin and hot flushes.

Finasteride treatment makes the prostate look more like a healthy one.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.